Deep learning-based automated lesion segmentation on mouse stroke magnetic resonance images.

Journal: Scientific reports
Published Date:

Abstract

Magnetic resonance imaging (MRI) is widely used for ischemic stroke lesion detection in mice. A challenge is that lesion segmentation often relies on manual tracing by trained experts, which is labor-intensive, time-consuming, and prone to inter- and intra-rater variability. Here, we present a fully automated ischemic stroke lesion segmentation method for mouse T2-weighted MRI data. As an end-to-end deep learning approach, the automated lesion segmentation requires very little preprocessing and works directly on the raw MRI scans. We randomly split a large dataset of 382 MRI scans into a subset (n = 293) to train the automated lesion segmentation and a subset (n = 89) to evaluate its performance. We compared Dice coefficients and accuracy of lesion volume against manual segmentation, as well as its performance on an independent dataset from an open repository with different imaging characteristics. The automated lesion segmentation produced segmentation masks with a smooth, compact, and realistic appearance that are in high agreement with manual segmentation. We report dice scores higher than the agreement between two human raters reported in previous studies, highlighting the ability to remove individual human bias and standardize the process across research studies and centers.

Authors

  • Jeehye An
    Department of Experimental Neurology and Center for Stroke Research, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Leo Wendt
    Scalable Minds GmbH, Potsdam, Germany.
  • Georg Wiese
    Scalable Minds GmbH, Potsdam, Germany.
  • Tom Herold
    Scalable Minds GmbH, Potsdam, Germany.
  • Norman Rzepka
    Scalable Minds GmbH, Potsdam, Germany.
  • Susanne Mueller
    Department of Experimental Neurology and Center for Stroke Research, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Stefan Paul Koch
    Department of Experimental Neurology and Center for Stroke Research, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Christian J Hoffmann
    Department of Neurology and Department of Experimental Neurology, Neurocure Cluster of Excellence, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Christoph Harms
    Department of Neurology and Department of Experimental Neurology, Neurocure Cluster of Excellence, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Philipp Boehm-Sturm
    Department of Experimental Neurology and Center for Stroke Research, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. philipp.boehm-sturm@charite.de.